These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


467 related items for PubMed ID: 14600590

  • 1. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA, Chirgwin JM.
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM, Guise TA.
    Crit Rev Eukaryot Gene Expr; 2000 Oct; 10(2):159-78. PubMed ID: 11186331
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer metastasis to bone: it is not all about PTHrP.
    Bendre M, Gaddy D, Nicholas RW, Suva LJ.
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM, Mundy GR.
    Cancer; 2003 Feb 01; 97(3 Suppl):834-9. PubMed ID: 12548583
    [Abstract] [Full Text] [Related]

  • 5. Tumor-bone cellular interactions in skeletal metastases.
    Chirgwin JM, Mohammad KS, Guise TA.
    J Musculoskelet Neuronal Interact; 2004 Sep 01; 4(3):308-18. PubMed ID: 15615499
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer bone metastasis and current small therapeutics.
    Cicek M, Oursler MJ.
    Cancer Metastasis Rev; 2006 Dec 01; 25(4):635-44. PubMed ID: 17160709
    [Abstract] [Full Text] [Related]

  • 7. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Löwik C.
    J Bone Miner Res; 2001 Jun 01; 16(6):1077-91. PubMed ID: 11393785
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R, Sourla A, Lembessis P, Koutsilieris M.
    Anticancer Res; 2006 Jun 01; 26(1A):283-91. PubMed ID: 16475708
    [Abstract] [Full Text] [Related]

  • 11. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA, Edwards JR, Martin TJ, Mundy GR.
    Bone; 2011 Jan 01; 48(1):6-15. PubMed ID: 20643235
    [Abstract] [Full Text] [Related]

  • 12. Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment.
    Chirgwin JM, Guise TA.
    J Cell Biochem; 2007 Dec 15; 102(6):1333-42. PubMed ID: 17907152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.